Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
NEDD9/CASL/HEF1 Antibody (2G9), Alexa Fluor™ 350, Novus Biologicals™

Mouse Monoclonal Antibody
Supplier: Novus Biologicals NB1001699AF350
Description
NEDD9/CASL/HEF1 Monoclonal specifically detects NEDD9/CASL/HEF1 in Human, Mouse, Rat samples. It is validated for Western Blot, ELISA, Immunocytochemistry/Immunofluorescence.Specifications
NEDD9/CASL/HEF1 | |
Monoclonal | |
Alexa Fluor 350 | |
50mM Sodium Borate with 0.05% Sodium Azide | |
NEDD9 | |
NEDD9/CASL/HEF1 Antibody (2G9) was produced by repeated immunizations with a synthetic peptide corresponding to amino acid residues 82-398 of human NEDD9/CASL/HEF1 protein (hNEDD9/CASL/HEF1, 843 aa, predicted MW 92.8 kDa). (Uniprot: Q14511) | |
0.1 mL | |
4739.0 | |
Human, Mouse, Rat | |
IgG1 κ |
Western Blot, ELISA, Immunocytochemistry, Immunofluorescence | |
2G9 | |
Western Blot, ELISA, Immunocytochemistry/Immunofluorescence | |
Cas scaffolding protein family member 2, CAS2, CasL, CAS-LCASS2cas-like docking, CASLdJ49G10.2, CRK-associated substrate-related protein, dJ49G10.2 (Enhancer of Filamentation 1 (HEF1)), dJ761I2.1, dJ761I2.1 (enhancer of filamentation (HEF1)), enhancer of filamentation 1, hEF1, HEF1Crk-associated substrate related, NEDD-9, Neural precursor cell expressed developmentally down-regulated protein 9, neural precursor cell expressed, developmentally down-regulated 9, p105, Renal carcinoma antigen NY-REN-12 | |
Mouse | |
Protein A purified | |
Primary | |
This Protein A purified antibody is directed against human HEF1 protein. Reactivity occurs against human, mouse and rat forms of the protein. Reactivity against multiple isoforms is expected. Reactivity against homologues from other sources is not known. Specificity was determined by partial epitope mapping. | |
Store at 4°C in the dark. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction